Sean Tunis

Summary

Publications

  1. pmc Effectiveness Guidance Document (EGD) for acupuncture research - a consensus document for conducting trials
    Claudia M Witt
    Institute for Social Medicine, Epidemiology and Health Economics, Charite University Medical Center, Berlin, Germany
    BMC Complement Altern Med 12:148. 2012
  2. doi request reprint Using health technology assessment to identify gaps in evidence and inform study design for comparative effectiveness research
    Sean R Tunis
    Center for Medical Technology Policy, World Trade Center Baltimore, Baltimore, MD 21202, USA
    J Clin Oncol 30:4256-61. 2012
  3. doi request reprint The National Oncologic PET Registry: lessons learned for coverage with evidence development
    Sean Tunis
    Center for Medical Technology Policy, Baltimore, Maryland 21202, USA
    J Am Coll Radiol 6:360-5. 2009
  4. doi request reprint Comparative effectiveness research: Policy context, methods development and research infrastructure
    Sean R Tunis
    Center for Medical Technology Policy, World Trade Center Baltimore, 401 E Pratt St, Suite 631, Baltimore, MD 21201, USA
    Stat Med 29:1963-76. 2010
  5. doi request reprint Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trials
    C Daniel Mullins
    University of Maryland School of Pharmacy, Baltimore, Maryland, USA
    Pharmacoeconomics 28:969-76. 2010
  6. doi request reprint Recommendations for clinical trials of off-label drugs used to treat advanced-stage cancer
    C Daniel Mullins
    University of Maryland, School of Pharmacy, 220 Arch St, 12th Floor, Baltimore, MD 21201, USA
    J Clin Oncol 30:661-6. 2012
  7. doi request reprint Ethics and informed consent for comparative effectiveness research with prospective electronic clinical data
    Ruth Faden
    Johns Hopkins Berman Institute of Bioethics, Baltimore, MD 21205, USA
    Med Care 51:S53-7. 2013
  8. ncbi request reprint Using clinical trials as a condition of coverage: lessons from the National Emphysema Treatment Trial
    Tanisha Carino
    Centers for Medicare and Medicaid Services, Coverage and Analysis Group, 7500 Security Boulevard, Baltimore, MD 21244, USA
    Clin Trials 1:108-14; discussion 115-21. 2004
  9. doi request reprint Uncertainty in assessing value of oncology treatments
    C Daniel Mullins
    Center for Medical Technology Policy, Baltimore, Maryland, USA
    Oncologist 15:58-64. 2010

Collaborators

Detail Information

Publications9

  1. pmc Effectiveness Guidance Document (EGD) for acupuncture research - a consensus document for conducting trials
    Claudia M Witt
    Institute for Social Medicine, Epidemiology and Health Economics, Charite University Medical Center, Berlin, Germany
    BMC Complement Altern Med 12:148. 2012
    ..The aim of this EGD is to provide specific recommendations for the design of prospective acupuncture studies to support optimal use of resources for generating evidence that will inform stakeholder decision-making...
  2. doi request reprint Using health technology assessment to identify gaps in evidence and inform study design for comparative effectiveness research
    Sean R Tunis
    Center for Medical Technology Policy, World Trade Center Baltimore, Baltimore, MD 21202, USA
    J Clin Oncol 30:4256-61. 2012
    ..Recent efforts are beginning to demonstrate the potential to build on the work invested in developing HTA reports to provide a roadmap toward these objectives...
  3. doi request reprint The National Oncologic PET Registry: lessons learned for coverage with evidence development
    Sean Tunis
    Center for Medical Technology Policy, Baltimore, Maryland 21202, USA
    J Am Coll Radiol 6:360-5. 2009
    ....
  4. doi request reprint Comparative effectiveness research: Policy context, methods development and research infrastructure
    Sean R Tunis
    Center for Medical Technology Policy, World Trade Center Baltimore, 401 E Pratt St, Suite 631, Baltimore, MD 21201, USA
    Stat Med 29:1963-76. 2010
    ..The approach to addressing each of these issues should be informed by the understanding that the primary purpose of CER is to help health care decision makers make informed clinical and health policy decisions...
  5. doi request reprint Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trials
    C Daniel Mullins
    University of Maryland School of Pharmacy, Baltimore, Maryland, USA
    Pharmacoeconomics 28:969-76. 2010
    ....
  6. doi request reprint Recommendations for clinical trials of off-label drugs used to treat advanced-stage cancer
    C Daniel Mullins
    University of Maryland, School of Pharmacy, 220 Arch St, 12th Floor, Baltimore, MD 21201, USA
    J Clin Oncol 30:661-6. 2012
    ....
  7. doi request reprint Ethics and informed consent for comparative effectiveness research with prospective electronic clinical data
    Ruth Faden
    Johns Hopkins Berman Institute of Bioethics, Baltimore, MD 21205, USA
    Med Care 51:S53-7. 2013
    ..Although many retrospective studies have relied on ECD, new study designs propose using ECD for prospective CER. These designs have great potential but they also raise important ethics questions...
  8. ncbi request reprint Using clinical trials as a condition of coverage: lessons from the National Emphysema Treatment Trial
    Tanisha Carino
    Centers for Medicare and Medicaid Services, Coverage and Analysis Group, 7500 Security Boulevard, Baltimore, MD 21244, USA
    Clin Trials 1:108-14; discussion 115-21. 2004
    ....
  9. doi request reprint Uncertainty in assessing value of oncology treatments
    C Daniel Mullins
    Center for Medical Technology Policy, Baltimore, Maryland, USA
    Oncologist 15:58-64. 2010
    ....